Ignite Creation Date:
2024-05-05 @ 5:26 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00455000
Status:
COMPLETED
Last Update Posted:
2009-10-14
First Post:
2007-03-29
Brief Title:
A Phase I Single IV Dose Of PF-04360365 In Adults With Mild To Moderate Alzheimers Disease
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A Phase I Randomized Placebo Controlled Double Blind Dose Escalation Study Of The Safety Tolerability PharmacokineticsPharmacodynamics And Immunogenicity Of A Single Intravenous Dose Of PF-04360365 In Adults With Mild To Moderate Alzheimers Disease
Status:
COMPLETED
Status Verified Date:
2009-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is determine whether a single IV dose of PF-04360365 is safe and well tolerated in Adults with Mild to Moderate Alzheimers disease
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None